期刊文献+

2型糖尿病和糖尿病肾病与C反应蛋白的临床关系

Relationship between plasma concentration of C-reactive protein in type 2 diabetes mellitus and diabetic nephropathies
暂未订购
导出
摘要 目的:观察单纯2型糖尿病(T2DM)和糖尿病肾病(DN)患者血清C-反应蛋白(CRP)的变化,探讨其在糖尿病及DN发生发展中的影响。方法:将98例住院患者及门诊健康体检者分为正常对照30例,T2DM组68例,其中单纯糖尿病组36例,DN组32例,用酶联免疫吸附法测定血浆CRP,并与正常对照组比较。结果:正常对照组CRP低于T2DM组,单纯T2DM组低于DN组。组间比较差异有显著性意义(P<0.05),单因素相关分析显示,CRP与空腹血糖、低密度脂蛋白、体重指数呈正相关,与高密度脂蛋白呈负相关。与年龄、TC、血压、HOMA-IR等无关。结论:CRP与T2DM和DN的发生发展相关,CRP可作为早期诊断、治疗T2DM和DN及预测其预后的参考指标。 Objective:To observe the pIasma concentration of C-reactive protein (CRP) in type 2 diabetes mellitus (T2DM) with/ without diabetic nephroprathies (DN), and explore the influences of CRP in the genesis and development of them. Methods:We selected 98 patients in our hospital and divided them into 2 groups: normal control group and T2DM group,including simple T2DM and diabetic nephroprathies.in addition,we measured the plasma CRP with ELISA.Results:The plasma CRP concentration in the control group was lower than that in T2DM group, and the level in simple T2DM patients was lower than that in the diabetic nephropathy patients,with an obviously decreased tendency,and the significant difference was found in the plasma CRP concentration among groups (P〈0.05). The correlation analysis showed that the plasma CRP concentration was positively correlated with FPG,LDL-C,BMI,negatively correlated with HDL-C,but not correlated with age,TC,BP and HOMA-IR.Conclusion:There may be relation between plasma concentrations of CRP and the occurrence of T2DM and DN. CRP can be taken as the index for the early diagnosis.treatment and prediction of prognosis in the patients with T2DM and DN.
出处 《现代医药卫生》 2008年第19期2874-2876,共3页 Journal of Modern Medicine & Health
关键词 糖尿病 糖尿病肾病 C-反应蛋白 胰岛素抵抗 Diabetic mellitus Diabetic nephropathy CRP Insulin resistance
  • 相关文献

参考文献5

二级参考文献15

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:253
  • 2Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:Diagnosis and classification of diabetes mellitus-provisional report of a WHO consultation.Diabet Med,1998,15(7):539-553
  • 3Thompson SG,Kienast J,Pyke SOM,et al.Hemostatic factors and the risk of myocardial infarction or solden death in patients with angina pectoris.N Eng J Med,1995,332(4):635-641
  • 4Sterm MP.Diabetes and cardiovascular disease:the "common soil" hypothesis.Diabetes,1995,44:369-374
  • 5Azen SP,Peters RK,Berkowitz K,et al.TRIPOD (Troglitazone In the Prevention of Diabetes):a randomized,placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.Control Clin Trials,1998,19:217-231
  • 6The Heart Outcomes Prevention Evaluation Study Investigations.Effects of an angiotension-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients.N Engl J Med,2000,342:145-15
  • 7Turner RC,Millns H,Neil HA,et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus(UKPDS:23).BMJ,1998,31:823-828
  • 8Ross R.Atherosclerosis:an inflammatory disease.N Engl J Med,1999,340:115-126
  • 9Lay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study.Diabetes,2001,50:2348-2389
  • 10Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部